In lung cancer, KRAS is one of the most frequent genetic alterations, and its expression is associated with pathological features, prognosis, and response to therapy [28, 29].In this manuscript, we show that high expression of miR-34c is correlated with survival in lung-adenocarcinoma patients carrying KRAS mutations. This evidence concerns the gene KRAS and lung cancer.